DE1493558A1 - Neue Peptidkomplexe mit adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung - Google Patents
Neue Peptidkomplexe mit adrenocorticotroper Wirkung und Verfahren zu ihrer HerstellungInfo
- Publication number
- DE1493558A1 DE1493558A1 DE19651493558 DE1493558A DE1493558A1 DE 1493558 A1 DE1493558 A1 DE 1493558A1 DE 19651493558 DE19651493558 DE 19651493558 DE 1493558 A DE1493558 A DE 1493558A DE 1493558 A1 DE1493558 A1 DE 1493558A1
- Authority
- DE
- Germany
- Prior art keywords
- lysyl
- zinc
- arginyl
- valyl
- tyrosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 12
- 238000002360 preparation method Methods 0.000 title claims description 5
- 230000003023 adrenocorticotropic effect Effects 0.000 title description 3
- 108090000765 processed proteins & peptides Proteins 0.000 title description 2
- 150000003751 zinc Chemical class 0.000 claims description 10
- 108010091893 Cosyntropin Proteins 0.000 claims description 8
- ZOEFCCMDUURGSE-SQKVDDBVSA-N cosyntropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 ZOEFCCMDUURGSE-SQKVDDBVSA-N 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 7
- 229960001423 tetracosactide Drugs 0.000 claims description 7
- 229910052725 zinc Inorganic materials 0.000 claims description 7
- OMSYGYSPFZQFFP-UHFFFAOYSA-J zinc pyrophosphate Chemical compound [Zn+2].[Zn+2].[O-]P([O-])(=O)OP([O-])([O-])=O OMSYGYSPFZQFFP-UHFFFAOYSA-J 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 4
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 4
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 4
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 4
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 3
- 239000004246 zinc acetate Substances 0.000 claims description 3
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 claims description 2
- 235000011180 diphosphates Nutrition 0.000 claims 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940048084 pyrophosphate Drugs 0.000 claims 1
- 239000000725 suspension Substances 0.000 description 16
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 9
- 239000002245 particle Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000019445 benzyl alcohol Nutrition 0.000 description 3
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 3
- 229960000258 corticotropin Drugs 0.000 description 3
- 101800000414 Corticotropin Proteins 0.000 description 2
- 102400000739 Corticotropin Human genes 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 101100128278 Mus musculus Lins1 gene Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH524261A CH471819A (de) | 1961-05-04 | 1961-05-04 | Verfahren zur Herstellung neuer Tetrakosapeptide |
| CH1375361A CH506485A (de) | 1961-05-04 | 1961-11-24 | Verfahren zur Herstellung von Schwermetallkomplexen neuer Tetrakosapeptide |
| CH920862 | 1962-08-01 | ||
| CH220863 | 1963-02-21 | ||
| CH220963A CH485670A (de) | 1961-05-04 | 1963-02-21 | Verfahren zur Herstellung eines Tetracosapeptids |
| CH492563 | 1963-04-19 | ||
| CH25164 | 1964-01-10 | ||
| CH888264A CH490337A (de) | 1964-07-07 | 1964-07-07 | Verfahren zur Herstellung von Tetracosapeptid-Zink-Pyrophosphat-Komplexen mit adrenocorticotroper Wirkung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1493558A1 true DE1493558A1 (de) | 1969-05-14 |
Family
ID=27570307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19651493558 Pending DE1493558A1 (de) | 1961-05-04 | 1965-07-03 | Neue Peptidkomplexe mit adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE666472A (nl) |
| DE (1) | DE1493558A1 (nl) |
| FR (2) | FR4808M (nl) |
| GB (1) | GB1053177A (nl) |
| NL (1) | NL6508678A (nl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4113858A (en) * | 1975-01-20 | 1978-09-12 | St. Luke's Hospital | Novel compounds, compositions and methods of their use |
| WO2016138436A2 (en) * | 2015-02-26 | 2016-09-01 | Retrophin, Inc. | Adrenocorticotropic hormone analogue formulations |
-
0
- FR FR88722D patent/FR88722E/fr not_active Expired
- GB GB1053177D patent/GB1053177A/en active Active
-
1965
- 1965-07-03 DE DE19651493558 patent/DE1493558A1/de active Pending
- 1965-07-06 BE BE666472A patent/BE666472A/xx unknown
- 1965-07-06 NL NL6508678A patent/NL6508678A/xx unknown
- 1965-09-07 FR FR30589A patent/FR4808M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL6508678A (nl) | 1966-01-10 |
| FR4808M (nl) | 1967-02-06 |
| FR88722E (nl) | 1967-06-02 |
| GB1053177A (nl) | |
| BE666472A (nl) | 1966-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0044050B1 (de) | Verfahren zur Herstellung von Eisen (III)-Hydroxid-Dextran-Komplexen und diese enthaltende pharmazeutische sterile Lösung | |
| DE1493558A1 (de) | Neue Peptidkomplexe mit adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung | |
| DE1467827A1 (de) | Gelartige Zubereitungen mit Hilfe von Salzen quaternaerer Ammoniumverbindungen | |
| DE1210865B (de) | Verfahren zur Herstellung des 2, 6-dioxo-tetrahydropyrimidin-4-carbonsauren Salzes des 4-Amino-5-imidazolcarbonsaeureamids | |
| DE952627C (de) | Verfahren zur Gewinnung von Vanadiumoxyden aus waessrigen Loesungen | |
| CH490337A (de) | Verfahren zur Herstellung von Tetracosapeptid-Zink-Pyrophosphat-Komplexen mit adrenocorticotroper Wirkung | |
| US2290235A (en) | Pest control | |
| Zerbst-Boroffka | Organische Säurereste als wichtigste Anionen im Blut von Hirudo medicinalis | |
| DE964949C (de) | Verfahren zur Herstellung lagerbestaendiger Loesungen zum Flammfestmachen von Fasermaterial auf Cellulosebasis | |
| DE1916254C3 (de) | Verfahren zum Verhindern von Ausfällungen bzw. zum Wiederauflösen vorhandener Trübungen in wäßrigen Lösungen von Aminocarbonsäuren | |
| DE829166C (de) | Verfahren zur Herstellung von N-(p-Arsenosobenzyl)-glycinamid und dessen Salzen | |
| DE870006C (de) | Verfahren zur Erzeugung von p-Aminobenzoyldiaethylaminoaethanol-Penicillin-Kristallen in Form von Plaettchen | |
| DE640004C (de) | Herstellung von Ammoniumazid | |
| DE692417C (de) | Verfahren zur Herstellung hochmolekularer N-Alkylpyridiniumhalogenide | |
| DE1592253C (de) | Verfahren zur Herstellung einer sta bilen Silberlosung | |
| AT144033B (de) | Verfahren zur Darstellung einer Verbindung des Theophyllins mit Diäthylolamin. | |
| DE671827C (de) | Seifenersatzstoffe | |
| DE688701C (de) | Bekaempfung von Pflanzenschaedlingen | |
| AT220285B (de) | Verfahren zur Herstellung von Insulinpräparaten mit protrahierter Wirkung | |
| DE800860C (de) | Verfahren zur Herstellung von reinem Selen | |
| DE2164399C3 (de) | Verfahren zur Reinigung von Alkalimetallsalzen der 7-(2'-Thienylacetamido)cephalosporansäure | |
| DE670048C (de) | Verfahren zur Schwimmaufbereitung nichtsulfidischer Mineralien unter Zusatz eines Salzes einer sulfurierten Fettsaeure | |
| DE601285C (de) | Verfahren zur Herstellung aktiven Schwefel enthaltender Produkte | |
| AT49735B (de) | Verfahren zur Darstellung von Derivaten aromatischer Ammoniumverbindungen. | |
| DE270255C (nl) |